Unknown

Dataset Information

0

GABAA-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice.


ABSTRACT: There is an urgent need for new approaches to limit the severity of coronavirus infections. Many cells of the immune system express receptors for the neurotransmitter γ-aminobutyric acid (GABA), and GABA-receptor (GABA-R) agonists have anti-inflammatory effects. Lung epithelial cells also express GABA-Rs, and GABA-R modulators have been shown to limit acute lung injuries. There is currently, however, no information on whether GABA-R agonists might impact the course of a viral infection. Here, we assessed whether clinically applicable GABA-R agonists could be repurposed for the treatment of a lethal coronavirus (murine hepatitis virus 1, MHV-1) infection in mice. We found that oral GABA administration before, or after the appearance of symptoms, very effectively limited MHV-1-induced pneumonitis, severe illness, and death. GABA treatment also reduced viral load in the lungs, suggesting that GABA-Rs may provide a new druggable target to limit coronavirus replication. Treatment with the GABAA-R-specific agonist homotaurine, but not the GABAB-R-specific agonist baclofen, significantly reduced the severity of pneumonitis and death rates in MHV-1-infected mice, indicating that the therapeutic effects were mediated primarily through GABAA-Rs. Since GABA and homotaurine are safe for human consumption, they are promising candidates to help treat coronavirus infections.

SUBMITTER: Tian J 

PROVIDER: S-EPMC8224554 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9640739 | biostudies-literature
| S-EPMC3776850 | biostudies-literature
| S-EPMC4897876 | biostudies-literature
| S-EPMC2804419 | biostudies-literature
2013-06-15 | GSE44333 | GEO
2013-06-15 | E-GEOD-44333 | biostudies-arrayexpress
| S-EPMC2744266 | biostudies-literature
| S-EPMC9533442 | biostudies-literature
| S-EPMC190114 | biostudies-other
| S-EPMC5969218 | biostudies-literature